Mandate

Vinge advises Aspiro in connection with a public takeover offer from S. Carter Enterprises

February 01, 2015

Vinge advises Aspiro AB (publ) in connection with the public takeover offer from Project Panther Bidco Ltd, indirectly owned by  S. Carter Enterprises, LLC, which is controlled by Shawn Carter. All shareholders of Aspiro are offered SEK 1.05 in cash per share in Aspiro and the total value of the offer amounts to approx. MSEK 464. The acceptance period for the offer is expected to begin on or about 19 February 2015 and expire on or about 11 March 2015. The offer is, inter alia, conditional upon that it is accepted to the extent that Panther becomes the owner of more than 90 per cent of the total number of shares in Aspiro and that Panther receives the necessary regulatory approvals for the acquisition.

Vinge’s team primarily consisted of Jesper Schönbeck, Johan Rickfors and Nils Fredrik Dehlin.

Aspiro is a media technology company in the forefront of the ongoing redefinition of music consumption. Through the subscription services WiMP and TIDAL, Aspiro offers a complete experience of higher HiFi quality. The platform encompasses audio, video and integrated editorial features. In parallel, Aspiro is a content provider to the online media industry through RADR, helping its partners to attract and retain visitors on their web sites. For more information, please visit www.aspiro.com

 

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025